IS THERE A ROLE FOR IN-VIVO METHYLENE-BLUE STAINING IN THE PREDICTION OF BLADDER-TUMOR RECURRENCE

被引：21

作者：

CREAGH, TA

GLEESON, M

TRAVIS, D

GRAINGER, R

MCDERMOTT, TED

BUTLER, MR

机构：

[1] MEATH HOSP, DUBLIN, IRELAND

[2] CENT MIDDLESEX HOSP, DEPT UROL, LONDON, ENGLAND

来源：

BRITISH JOURNAL OF UROLOGY | 1995年 / 75卷 / 04期

关键词：

BLADDER TUMOR; RECURRENCE; PREDICTION; METHYLENE BLUE;

D O I：

10.1111/j.1464-410X.1995.tb07268.x

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Objective To assess the role of in vivo staining with intravesical methylene blue in predicting tumour recurrence. Patients and Methods Thirty-nine patients (27 men and 12 women, age range 43-75 years) newly diagnosed with bladder tumours were prospectively studied and followed for a minimum of 2 years. Potential biopsy sites were identified by staining intravesically with a 1% methylene blue solution and compared with random biopsy sites. Results Biopsy directed by methylene blue staining detected carcinoma in situ more often than random biopsy. Rates of recurrence were similar in both stained and unstained groups. Conclusion Methylene blue staining does not add significantly to the management of patients presenting with bladder tumours.

引用

页码：477 / 479

页数：3

共 6 条

[1]

Loss LG., Mapping of the urinary bladder:its impact on the concepts of bladder cancer, Hum Pathol, 10, pp. 533-548, (1979)

[2]

Smith G., Elton RA, Beynon LL, Newsam JE, Chisholm GD, Hargreave TB., Prognostic significance of biopsy results of normal looking mucosa in cases of superficial bladder cancer, Br J Urol, 55, pp. 665-669, (1983)

[3]

Gill WB, Strauss FH., In vivo mapping of bladder cancer (chromocystoscopy for in vivo detection of neoplastic urothelial surfaces), Urology, 23, 4, pp. 63-66, (1984)

[4]

Mufti GR, Shah PJR, Parkinson HC, Riddle PR., Diagnosis of clinically occult bladder Cancer by in vivo staining with methylene blue, Br J Urol, 65, pp. 173-175, (1990)

[5]

Abel PD., Follow up of patients with ‘superficial’ transitional cell carcinoma oí the bladder:the case for a change in policy, Br J Urol, 72, pp. 135-142, (1993)

[6]

Kiemeney LALM, Witjes JA, Heijbroek RP, Et al., Should random biopsy be taken from patients with superficial bladder cancer? A decision analysis, Br J Urol, 73, pp. 164-171, (1994)

← 1 →